"In the wake of subpar Q3 earnings, Altria sold-off. When the company reported on Oct. 30, it announced: Adjusted EPS of $1.45, exceeding analyst expectations. Total revenue declined 3% year over year due to lower sales in smokeable and oral tobacco segments Full-year 2025 adjusted EPS guidance was narrowed to $5.37 to $5.45, suggesting annual growth of 3.5% to 5%. The company expanded its share repurchase plan to $2 billion, and extended the program through December 2026."
"Among iconic American brands, Altria's Marlboro cigarettes are as recognizable as iPhones, Levi Jeans and Coca-Cola. While the company's origins can be traced back to George Weyman's tobacco shop in 1822, Altria filed its first annual report as Philip Morris in 1920 and would come to dominate U.S. tobacco throughout the 20 th century and beyond. As Philip Morris branched out to acquire General Foods and Kraft, among others, it changed its name in 2003 to Altria Group while retaining the "MO" ticker."
Altria's shares rose 3.79% over the last month and are up 12.02% in 2025 while yielding 7.21%. The company has increased its dividend 60 times over 56 years. Q3 results showed adjusted EPS of $1.45, total revenue down 3% year over year, and full-year 2025 adjusted EPS guidance narrowed to $5.37–$5.45, implying 3.5%–5% growth. The company expanded its share repurchase program to $2 billion and extended it through December 2026. Marlboro remains a dominant brand, and Altria's slower growth reflects regulatory and health pressures but it retains historical reliability.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]